1E1G | A:125-228 | HUMAN PRION PROTEIN VARIANT M166V |
1E1J | A:125-228 | HUMAN PRION PROTEIN VARIANT M166V |
1E1P | A:125-228 | HUMAN PRION PROTEIN VARIANT S170N |
1E1S | A:125-228 | HUMAN PRION PROTEIN VARIANT S170N |
1E1U | A:125-228 | HUMAN PRION PROTEIN VARIANT R220K |
1E1W | A:125-228 | HUMAN PRION PROTEIN VARIANT R220K |
1FKC | A:125-231 | HUMAN PRION PROTEIN (MUTANT E200K) FRAGMENT 90-231 |
1FO7 | A:125-231 | HUMAN PRION PROTEIN MUTANT E200K FRAGMENT 90-231 |
1H0L | A:119-230 | HUMAN PRION PROTEIN 121-230 M166C/E221C |
1HJM | A:125-228 | HUMAN PRION PROTEIN AT PH 7.0 |
1HJN | A:125-228 | HUMAN PRION PROTEIN AT PH 7.0 |
1I4M | A:119-226 | CRYSTAL STRUCTURE OF THE HUMAN PRION PROTEIN REVEALS A MECHANISM FOR OLIGOMERIZATION |
1LG4 | A:52-150 | NMR STRUCTURE OF THE HUMAN DOPPEL PROTEIN FRAGMENT 24-152 |
1QLX | A:125-228 | HUMAN PRION PROTEIN |
1QLZ | A:125-228 | HUMAN PRION PROTEIN |
1QM0 | A:125-228 | HUMAN PRION PROTEIN FRAGMENT 90-230 |
1QM1 | A:125-228 | HUMAN PRION PROTEIN FRAGMENT 90-230 |
1QM2 | A:125-228 | HUMAN PRION PROTEIN FRAGMENT 121-230 |
1QM3 | A:125-228 | HUMAN PRION PROTEIN FRAGMENT 121-230 |
2K1D | A:125-231 | NMR STUDIES OF A PATHOGENIC MUTANT (D178N) OF THE HUMAN PRION PROTEIN |
2W9E | A:125-223 | STRUCTURE OF ICSM 18 (ANTI-PRP THERAPEUTIC ANTIBODY) FAB FRAGMENT COMPLEXED WITH HUMAN PRP FRAGMENT 119-231 |
3HAF | A:120-225 | HUMAN PRION PROTEIN VARIANT V129 DOMAIN SWAPPED DIMER |
3HAK | A:125-227 | HUMAN PRION PROTEIN VARIANT V129 |
3HEQ | A:126-228; B:126-228 | HUMAN PRION PROTEIN VARIANT D178N WITH M129 |
3HER | A:125-226; B:126-227 | HUMAN PRION PROTEIN VARIANT F198S WITH V129 |
3HES | A:125-226; B:126-226 | HUMAN PRION PROTEIN VARIANT F198S WITH M129 |
3HJ5 | A:125-225; B:126-227 | HUMAN PRION PROTEIN VARIANT V129 DOMAIN SWAPPED DIMER |
3HJX | A:126-223 | HUMAN PRION PROTEIN VARIANT D178N WITH V129 |